AG Grewal Announces Action to Reduce Risk of Fatal Overdoses During COVID-19 Crisis: Administrative Order from Division of Consumer Affairs Requires NJ Practitioners to Co-Prescribe Naloxone to Certain At-Risk Opioid Patients During COVID-19 Emergency

New Jersey. Office of the Attorney GeneralGrewal, Gurbir S.Rodriguez, Paul R.Joyce, Sharon M.2020-10-292020-10-292020-05-21974.905 L464https://hdl.handle.net/10929/68549This record contains the associated New Jersey Division of Community Affairs Administrative Order No. 2020-08 Administrative Order and Notice of Rule Adoption Pursuant to P.L., c 18 Naloxone Prescribing by Health Care Practitionersen-USNew JerseyCovid 19Novel coronavirusLaw enforcementHealth and safetyAG Grewal Announces Action to Reduce Risk of Fatal Overdoses During COVID-19 Crisis: Administrative Order from Division of Consumer Affairs Requires NJ Practitioners to Co-Prescribe Naloxone to Certain At-Risk Opioid Patients During COVID-19 Emergency